Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 25;12(3):931.
doi: 10.3390/jcm12030931.

Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning

Affiliations

Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning

Rubén Queiro et al. J Clin Med. .

Abstract

The aim was to identify patient- and disease-related characteristics predicting moderate-to-high disease activity in recent-onset psoriatic arthritis (PsA). We performed a multicenter observational prospective study (2-year follow-up, regular annual visits) in patients aged ≥18 years who fulfilled the CASPAR criteria and had less than 2 years since the onset of symptoms. The moderate-to-high activity of PsA was defined as DAPSA > 14. We trained a logistic regression model and random forest-type and XGBoost machine learning algorithms to analyze the association between the outcome measure and the variables selected in the bivariate analysis. The sample comprised 158 patients. At the first follow-up visit, 20.8% of the patients who attended the clinic had a moderate-to-severe disease. This percentage rose to 21.2% on the second visit. The variables predicting moderate-high activity were the PsAID score, tender joint count, level of physical activity, and sex. The mean values of the measures of validity of the machine learning algorithms were all high, especially sensitivity (98%; 95% CI: 86.89-100.00). PsAID was the most important variable in the prediction algorithms, reinforcing the convenience of its inclusion in daily clinical practice. Strategies that focus on the needs of women with PsA should be considered.

Keywords: DAPSA; PsAID; arthritis; disease activity; machine learning; predictive model; psoriatic.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

    1. Ritchlin C.T., Colbert R.A., Gladman D.D. Psoriatic Arthritis. N. Engl. J. Med. 2017;376:957–970. doi: 10.1056/NEJMra1505557. - DOI - PubMed
    1. Pérez A.R., Queiro R., Seoane-Mato D., Graell E., Chamizo E., Chaparro L.C., Herrera S.R., Dolset J.P., Ostáriz M.A.P., Garrido S.R.-A., et al. Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study. PLoS ONE. 2020;15:e0234556. - PMC - PubMed
    1. Helliwell P.S., FitzGerald O., Fransen J. Composite disease activity and responder indices for psoriatic arthritis: A report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response. J. Rheumatol. 2014;41:1212–1217. doi: 10.3899/jrheum.140172. - DOI - PubMed
    1. Gossec L., Baraliakos X., Kerschbaumer A., de Wit M., McInnes I., Dougados M., Primdahl J., McGonagle D.G., Aletaha D., Balanescu A., et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann. Rheum. Dis. 2020;79:700–712. doi: 10.1136/annrheumdis-2020-217159. - DOI - PMC - PubMed
    1. Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.-S., Pinto-Tasende J.A., Baute J.J.B., Ibáñez B.J., Toniolo E., et al. Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: Predictive model based on machine learning. Arthritis Res. Ther. 2022;24:153. doi: 10.1186/s13075-022-02838-2. - DOI - PMC - PubMed

Grants and funding